Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL
暂无分享,去创建一个
J. Witztum | G. Silverman | P. Shaw | C. Goodyear | W. Palinski | C. Binder | Mi-Kyung Chang | S. Hörkkö | A. Dewan | E. Kieu
[1] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[2] J. Witztum,et al. Minimally Modified LDL Binds to CD14, Induces Macrophage Spreading via TLR4/MD-2, and Inhibits Phagocytosis of Apoptotic Cells* , 2003, The Journal of Biological Chemistry.
[3] J. M. Núñez-Cortés,et al. Infección, Chlamydia y arteriosclerosis , 2003 .
[4] J. Witztum,et al. Innate and acquired immunity in atherogenesis , 2002, Nature Medicine.
[5] J. Witztum,et al. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] Peter Libby,et al. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis , 2002, Circulation research.
[7] H. Wardemann,et al. B-1a B Cells that Link the Innate and Adaptive Immune Responses Are Lacking in the Absence of the Spleen , 2002, The Journal of experimental medicine.
[8] G. Hansson,et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. , 2002, The Journal of clinical investigation.
[9] E. Dennis,et al. Correlation of Antiphospholipid Antibody Recognition with the Structure of Synthetic Oxidized Phospholipids , 2002, The Journal of Biological Chemistry.
[10] R. Berland,et al. Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.
[11] Marc Bonneville,et al. Autoreactivity by design: innate B and T lymphocytes , 2001, Nature Reviews Immunology.
[12] J. Tew,et al. Phosphorylcholine-Dependent Cross-Reactivity between Dental Plaque Bacteria and Oxidized Low-Density Lipoproteins , 2001, Infection and Immunity.
[13] A. Daugherty,et al. Freunds adjuvant alone is antiatherogenic in apoE-deficient mice and specific immunization against TNFalpha confers no additional benefit. , 2001, Atherosclerosis.
[14] D. Steinberg,et al. Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. , 2001, Journal of lipid research.
[15] C. Snapper,et al. Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae. , 2001, Trends in immunology.
[16] J. Kearney,et al. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. , 2001, Immunity.
[17] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[18] G. Silverman,et al. A B Cell Superantigen–Induced Persistent “Hole” in the B-1 Repertoire , 2000, The Journal of experimental medicine.
[19] R. Zinkernagel,et al. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. , 2000, Science.
[20] G. Silverman,et al. Immunological responses to oxidized LDL. , 2000, Free radical biology & medicine.
[21] G. Silverman,et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.
[22] A. Lustig,et al. Highly reduced protection against Streptococcus pneumoniae after deletion of a single heavy chain gene in mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Dennis,et al. The Binding of Oxidized Low Density Lipoprotein to Mouse CD36 Is Mediated in Part by Oxidized Phospholipids That Are Associated with Both the Lipid and Protein Moieties of the Lipoprotein* , 2000, The Journal of Biological Chemistry.
[24] G. Silverman,et al. Neo-self antigens and the expansion of B-1 cells: lessons from atherosclerosis-prone mice. , 2000, Current topics in microbiology and immunology.
[25] R. Zinkernagel,et al. Control of early viral and bacterial distribution and disease by natural antibodies. , 1999, Science.
[26] E. Dennis,et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Dennis,et al. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. , 1999, The Journal of clinical investigation.
[28] E. Miller,et al. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[29] K. Warnatz,et al. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen. , 1998, Journal of immunology.
[30] J. Witztum,et al. The epitopes for some antiphospholipid antibodies are adducts of oxidized phospholipid and beta2 glycoprotein 1 (and other proteins). , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[31] A Daugherty,et al. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice. , 1997, The Journal of clinical investigation.
[32] F. Rosen,et al. Endotoxin shock in antibody-deficient mice: unraveling the role of natural antibody and complement in the clearance of lipopolysaccharide. , 1997, Journal of immunology.
[33] Wei Sha,et al. Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo * , 1997, The Journal of Biological Chemistry.
[34] J. D. Smith,et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[35] J. Witztum,et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. , 1996, The Journal of clinical investigation.
[36] E M Rubin,et al. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.
[37] E. Miller,et al. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Hansson,et al. Immune mechanisms in atherosclerosis. , 1994, Coronary artery disease.
[39] C. O'Connell,et al. Antigen binding and idiotype analysis of antibodies obtained after electroporation of heavy and light chain genes encoding phosphocholine- specific antibodies: a model for T15-idiotype dominance , 1992, The Journal of experimental medicine.
[40] H. Köhler,et al. Human anti-phosphorylcholine antibodies share idiotopes and are self-binding. , 1991, The Journal of clinical investigation.
[41] A. Coutinho,et al. All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. , 1990, International immunology.
[42] J L Witztum,et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.
[43] M. Scharff,et al. Rat anti-T15 monoclonal antibodies with specificity for VH- and VH-VL epitopes. , 1984, Molecular immunology.
[44] M. Rittenberg,et al. Subpopulations of antibodies to phosphocholine in human serum. , 1984, Journal of immunology.
[45] D. Briles,et al. Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae , 1982, The Journal of experimental medicine.
[46] J. Kearney,et al. Monoclonal vs. heterogeneous anti‐H‐8 antibodies in the analysis of the anti‐phosphorylcholine response in BALB/c mice , 1981, European journal of immunology.